Angitia Biopharma is a biopharmaceutical company dedicated to developing innovative medicines to treat severe diseases by targeting the mechanisms of action at their roots. With a focus on precision medicine, the company leverages cutting-edge technologies, including advanced molecular biology and drug discovery platforms, to create therapies that address significant unmet medical needs. Their commitment to excellence and collaboration is reflected in their multidisciplinary approach, integrating scientific research, clinical development, and patient-centric care. By partnering with global experts and fostering innovation, Angitia Biopharma aims to transform healthcare and improve the lives of patients worldwide.